Clinical Trial

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-06; most recent amendment 2026-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-02-24
Trial Details
NCT Number NCT06679036
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Advanced Unresectable or Metastatic Breast Cancer
Enrollment 300 participants
Start Date 2025-01-21
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02